V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough
MedTech & Diagnostics

Hologic Executive Compensation (FY24)

HOLX · Executive and director compensation, fiscal 2022 to 2024
Chief executive, fiscal 2024
◇
Stephen MacMillan
Latest say-on-pay support
=
February 26, 2025
Velarion Member: every covered company in MedTech & Diagnostics, with dashboards, peer screens and board-ready briefs. Three seats, one year.
Email me this page as a cited PDF — sent in 2 minutes
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.

The paid brief on Hologic

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
$1,500 for the Executive Compensation Report. Both reports for $2,400.
Get the executive briefGet the board briefNo account needed.
Data as of October 22, 2026Latest filing (8-K): February 28, 2025
12 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Hologic brief$1,500Get the executive brief
Velarion Member, one year
425 figures on this page: 415 cited to the filing that reported them, 10 calculated from figures it prints. See the citations

More on Hologic

Five data products on this company. Each one is requested through the developer setup page.
What changed from fiscal 2023 to fiscal 2024
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Stephen MacMillan: $15,555,032 → $15,819,261 (1.7% higher)

Frequently asked questions

Answers drawn from the data on this page.
Who is Hologic's chief executive and what were they paid?
Total compensation for Stephen MacMillan, Chairman, President and Chief Executive Officer, came to $15,819,261 in fiscal 2024. MacMillan's total was 1.7% higher than the $15,555,032 reported for fiscal 2023.
What was Hologic's say-on-pay result?
For fiscal 2024, shareholders backed the say-on-pay proposal with 83.6% of votes cast for or against in favor at the meeting held February 26, 2025.
Which companies are in Hologic's peer group?
Companies named in the disclosed peer group include Abbott Laboratories, Agilent Technologies, Inc., Baxter International Inc., Becton, Dickinson and Company and Boston Scientific Corporation, among others. The Primary Peer Group includes Agilent Technologies, Inc., Baxter International Inc., Boston Scientific Corporation, DENTSPLY Sirona, Inc. and Edwards Lifesciences Corp., among others. The TSR Peer Group names Bruker Corporation, DexCom, Inc., Integra LifeSciences Holdings Corp, Laboratory Corp. of America Holdings and Mettler-Toledo International Inc., among others. Companies named in the Supplemental Practices Peer Group include Becton, Dickinson and Company, Johnson & Johnson, Stryker Corporation and Thermo Fisher Scientific Inc.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Stephen MacMillan
Chairman, President and Chief Executive Officer
◇—◇◇◇—◇◇
Karleen Oberton
Chief Financial Officer
◇—◇◇◇—◇◇
Kevin Thornal
Group President, Global Diagnostics Solutions
◇—◇◇◇—◇◇
John Griffin
General Counsel
◇—◇◇◇—◇◇
Jan Verstreken
Group President, International
◇—◇◇◇—◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Stephen MacMillan
Chairman, President and Chief Executive Officer
◇—◇◇◇—◇◇
Karleen Oberton
Chief Financial Officer
◇—◇◇◇—◇◇
Jan Verstreken
Group President, International
◇—◇◇◇—◇◇
John Griffin
General Counsel
◇—◇◇◇—◇◇
Essex Mitchell
Chief Operating Officer
◇—◇◇◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Stephen MacMillan
Chairman, President and Chief Executive Officer
◇—◇◇◇—◇◇
Karleen Oberton
Chief Financial Officer
◇—◇◇◇—◇◇
Essex Mitchell
Chief Operating Officer
◇—◇◇◇—◇◇
Jan Verstreken
Group President, International
◇—◇◇◇—◇◇
John Griffin
General Counsel
◇—◇◇◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2024
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Essex D. MitchellPSU◇◇◇—◇—◇
Essex D. MitchellPSU◇◇◇—◇—◇
Essex D. MitchellPSU◇◇◇—◇—◇
Essex D. MitchellRSU◇——◇——◇
Essex D. MitchellOPTION◇——◇—◇◇
Jan VerstrekenPSU◇◇◇—◇—◇
Jan VerstrekenPSU◇◇◇—◇—◇
Jan VerstrekenRSU◇——◇——◇
Jan VerstrekenPSU◇◇◇—◇—◇
Jan VerstrekenOPTION◇——◇—◇◇
John M. GriffinPSU◇◇◇—◇—◇
John M. GriffinPSU◇◇◇—◇—◇
John M. GriffinPSU◇◇◇—◇—◇
John M. GriffinRSU◇——◇——◇
John M. GriffinOPTION◇——◇—◇◇
Karleen M. ObertonPSU◇◇◇—◇—◇
Karleen M. ObertonPSU◇◇◇—◇—◇
Karleen M. ObertonRSU◇——◇——◇
Karleen M. ObertonPSU◇◇◇—◇—◇
Karleen M. ObertonOPTION◇——◇—◇◇
Stephen P. MacMillanPSU◇◇◇—◇—◇
Stephen P. MacMillanRSU◇——◇——◇
Stephen P. MacMillanPSU◇◇◇—◇—◇
Stephen P. MacMillanPSU◇◇◇—◇—◇
Stephen P. MacMillanOPTION◇——◇—◇◇
Fiscal 2022, 2023 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2024 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Karleen ObertonPSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
PSU◇◇——
Option◇—◇11/9/2030
PSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇11/7/2032
Option◇—◇11/8/2031
Option◇—◇11/14/2033
Essex MitchellRSU◇◇——
Option◇—◇11/7/2032
PSU◇◇——
PSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇11/9/2030
Option◇—◇11/8/2031
Option◇—◇11/14/2033
Jan VerstrekenRSU◇◇——
RSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
PSU◇◇——
PSU◇◇——
Option◇—◇11/14/2033
RSU◇◇——
RSU◇◇——
Option◇—◇11/9/2030
Option◇—◇11/8/2031
Option◇—◇11/7/2032
Stephen MacMillanRSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇11/9/2030
Option◇—◇11/8/2031
Option◇—◇11/7/2032
Option◇—◇11/14/2033
John GriffinPSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
PSU◇◇——
Option◇—◇11/9/2030
RSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇11/8/2031
Option◇—◇11/7/2032
Option◇—◇11/14/2033
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Severance and change in control

The terms as written in the agreements.
Jan Verstreken
Group President, International · Employment agreement
Severance multiple◇
Change-in-control multiple◇
Stephen MacMillan
Chairman, President and Chief Executive Officer · Employment agreement
Severance multiple◇

Director compensation

What each non-employee director was paid.
Fiscal 2024
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Amy M. Wendell
Lead independent director
◇◇◇———◇
Sally W. Crawford
◇◇◇———◇
Charles J. Dockendorff
◇◇◇———◇
Scott T. Garrett
◇◇◇———◇
Nanaz Mohtashami
◇◇◇———◇
Stacey D. Stewart
◇◇◇———◇
Christiana Stamoulis
◇◇◇———◇
Ludwig N. Hantson
◇◇◇———◇
Namal Nawana
◇—————◇
Stephen P. MacMillan and Martin Madaus served on the board in fiscal 2024 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Lead independent director premium◇
Audit committee chair◇
Compensation committee chair◇
Nominating and governance chair◇
Nominating and governance member◇
Equity is delivered as RSUs and Options.

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2024
  • Abbott Laboratories ABT
  • Agilent Technologies, Inc. A
  • Baxter International Inc. BAX
  • Becton, Dickinson and Company BDX
  • Boston Scientific Corporation BSX
  • Bruker Corporation BRKR
  • DENTSPLY SIRONA Inc. XRAY
  • DexCom, Inc. DXCM
  • Edwards Lifesciences Corp. EW
  • IDEXX Laboratories, Inc. IDXX
  • Illumina, Inc. ILMN
  • Integra LifeSciences Holdings Corp IART
  • Intuitive Surgical, Inc. ISRG
  • Laboratory Corp. of America Holdings symbol not shown
  • Mettler-Toledo International Inc. MTD
  • Qiagen NV QGEN
  • Quest Diagnostics Inc. DGX
  • ResMed Inc. RMD
  • Revvity, Inc. RVTY
  • STERIS plc STE
  • Stryker Corporation SYK
  • The Cooper Companies, Inc. COO
  • Thermo Fisher Scientific Inc. TMO
  • Waters Corporation WAT
  • Zimmer Biomet Holdings, Inc. ZBH
Primary Peer Group
  • Agilent Technologies, Inc. A
  • Baxter International Inc. BAX
  • Boston Scientific Corporation BSX
  • DENTSPLY Sirona, Inc. XRAY
  • Edwards Lifesciences Corp. EW
  • IDEXX Laboratories, Inc. IDXX
  • Illumina, Inc. ILMN
  • Intuitive Surgical, Inc. ISRG
  • ResMed, Inc. RMD
  • Revvity, Inc. RVTY
  • Teleflex Incorporated TFX
  • The Cooper Companies, Inc. COO
  • Waters Corporation WAT
  • Zimmer Biomet Holdings, Inc. ZBH
TSR Peer Group
  • Bruker Corporation BRKR
  • DexCom, Inc. DXCM
  • Integra LifeSciences Holdings Corp IART
  • Laboratory Corp. of America Holdings symbol not shown
  • Mettler-Toledo International Inc. MTD
  • Quest Diagnostics Inc. DGX
Supplemental Practices Peer Group
  • Becton, Dickinson and Company BDX
  • Johnson & Johnson JNJ
  • Stryker Corporation SYK
  • Thermo Fisher Scientific Inc. TMO

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2024February 26, 2025=◇◇◇
2023March 7, 2024=◇◇◇
2022March 9, 2023=◇◇◇
2021March 10, 2022=◇◇◇
2020March 11, 2021=◇◇◇
2019March 5, 2020=◇◇◇
2018March 7, 2019=◇◇◇
2017March 14, 2018=◇◇◇
2016March 8, 2017=◇◇◇
2015March 2, 2016=◇◇◇

Velarion Pro: every company page, peer tools and exports, one seat

One seat, one person. It opens the whole platform: the peer tools, the written analysis and the exports, on every company we cover. Join the list and you will hear from us when it opens.
Your address is used for this and nothing else, and you can unsubscribe in one click. See the privacy policy.

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Stephen MacMillan (Chairman, President and Chief Executive Officer), FY2024 total compensation $15,819,261 (base salary $1,212,628) [exec_comp, SEC accession 0001140361-25-001287, filed 2025-01-16]

Answered within 24 hours, every figure cited to its SEC filing. If our database cannot answer your question, you are refunded automatically.

Tell me when Hologic files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Hologic disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Hologic sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $499
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for Peer Group Review
Whether Hologic's disclosed peer group is defensible, who names Hologic back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
425 figures on this page: 415 cited to the filing that reported them, 10 calculated from figures it prints.
415 cited to the filing
10 calculated from the filing

Documents cited

  1. 0001140361-25-006521
  2. 0001140361-25-001287
    Director Compensation · Grants of Plan-Based Awards · Outstanding Equity Awards at Fiscal Year End · Potential Payments upon Termination · and 1 more section
  3. 0000859737-24-000009
    887 3,069,052 166,054 11,348,557 Proposal 2.
  4. 0000859737-23-000006
    Item 5.07 Submission of Matters to a Vote of Security Holders
  5. 0001140361-23-002129
    Summary Compensation Table
  6. 0000859737-22-000007
    Item 5.07 Submission of Matters to a Vote of Security Holders
  7. 0000859737-21-000008
    Item 5.07 Submission of Matters to a Vote of Security Holders
  8. 0000859737-20-000015
  9. 0000859737-19-000008
  10. 0001193125-18-084012
    Item 5.07 Submission of Matters to a Vote of Security Holders
  11. 0000859737-17-000007
  12. 0000859737-16-000049
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Hologic executive compensation, FY2022–FY2024.” https://intel.velarion.ai/comp/HOLX (accessed 2026).
Short form: data: Velarion

The paid brief for Hologic

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
$1,500 for the Executive Compensation Report. Both reports for $2,400.
Get the executive briefGet the board briefNo account needed.
12 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Hologic and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

MedTech & Diagnostics rankings

Chief executive pay — MedTech & DiagnosticsCEO pay ratio — MedTech & DiagnosticsSay-on-pay support — MedTech & Diagnostics

Peers Hologic discloses

The companies named in HOLX's own disclosed peer group.

Abbott LaboratoriesAgilent Technologies, Inc.Baxter International Inc.Becton, Dickinson and CompanyBoston Scientific CorporationBruker CorporationDENTSPLY SIRONA Inc.DexCom, Inc.Edwards Lifesciences Corp.IDEXX Laboratories, Inc.Illumina, Inc.Integra LifeSciences Holdings CorpIntuitive Surgical, Inc.Mettler-Toledo International Inc.Quest Diagnostics Inc.ResMed Inc.Revvity, Inc.STERIS plcStryker CorporationThe Cooper Companies, Inc.Thermo Fisher Scientific Inc.Waters CorporationZimmer Biomet Holdings, Inc.Teleflex Incorporated

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  All companies · The Pay Desk · Methodology · Terms · Privacy